Ardsley Advisory Partners LP Harrow Health, Inc. Transaction History

Ardsley Advisory Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$4.71 - $7.36 $141,300 - $220,800	-30,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$4.6 - $7.88 $23,000 - $39,400	5,000 Added 20.0%	30,000 $233,000
Q3 2019 Nov 14, 2019	SELL	$4.89 - $8.0 $195,600 - $320,000	-40,000 Reduced 61.54%	25,000 $141,000
Q2 2019 Aug 13, 2019	SELL	$4.2 - $8.7 $42,000 - $87,000	-10,000 Reduced 13.33%	65,000 $566,000
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $356,250 - $532,500	75,000 New	75,000 $374,000

180

21.3M

845K

717K

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $901M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.